Entero Therapeutics, Inc.
ENTO
Revenue
0.00
0.000.00%
12 Months ChangeAssets
85.20M
▼-205.97k▼-0.2412%
3 Months ChangeLiabilities
28.74M
▲1.13M▲4.11%
3 Months ChangeFree Cash Flow
-5.07M
▼-3.78M▼-291.58%
12 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2024-10-21
Form 10-Q
ID: 0001410578-24-001685
2024-09-11
Form 8-K
ID: 0001104659-24-098971
2024-09-10
Form 8-K
ID: 0001104659-24-098369
2024-09-03
Form 8-K
ID: 0001104659-24-096362
2024-08-29
Form 8-K
ID: 0001104659-24-094936
2024-08-23
Form 8-K
ID: 0001104659-24-092491
2024-08-22
Form 8-K
ID: 0001104659-24-092061
2024-08-15
Form 8-K
ID: 0001104659-24-089923
2024-08-07
Form 8-K
ID: 0001104659-24-086824
2024-07-31
Form 8-K
ID: 0001104659-24-084206